glp 1 gip receptor agonist Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an Dual and Triple Gut Peptide

Bibcode:1993BBRC..196..141G

[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Sorli C., et al

Stefnsson E, Olafsdottir OB, Eliasdottir TS, et al

Currently, GLP-1 receptor agonists should only be used for FDA-approved indications such as type 2 diabetes or obesity

Pricing strategy: The pharmaceutical companies that produce GLP-1 drugs for weight loss have chosen a pricing strategy that focuses on maximizing profit from a smaller patient population rather than pursuing a lower profit margin across a larger customer base

FUTURE PERSPECTIVES The emergence of SGLT2 inhibitors and GLP1 receptor agonists represents a major advancement in the management of DKD